Lymphocyte Depleted Hodgkin Lymphoma, Lymph Nodes of Head, Face, and Neck (C81.31)

Name of the Condition

• Common Name: Lymphocyte Depleted Hodgkin Lymphoma, Lymph Nodes of Head, Face, and Neck
• Medical Terms: LD Hodgkin Lymphoma, Lymphocyte-Depleted Hodgkin Disease (head, face, and neck lymph nodes)

Summary

Lymphocyte depleted Hodgkin lymphoma (LD Hodgkin lymphoma) is a rare and aggressive subtype of Hodgkin lymphoma. It is characterized by a scarcity of lymphocytes and a predominance of Reed-Sternberg cells in affected lymph nodes or tissues. This subtype often presents at an advanced stage and may involve extranodal sites, such as the liver or bone marrow. LD Hodgkin lymphoma is associated with a poorer prognosis compared to other Hodgkin lymphoma subtypes, though treatment advances have improved outcomes.

Causes

The exact cause of lymphocyte depleted Hodgkin lymphoma is not fully understood. It is thought to result from a combination of genetic mutations and environmental factors. Unlike other Hodgkin lymphoma subtypes, Epstein-Barr virus (EBV) is frequently associated with LD Hodgkin lymphoma, suggesting a potential viral role in its development. Genetic abnormalities and immune system dysregulation may also contribute.

Risk Factors

• Age: Most commonly diagnosed in adults, particularly those over 50.
• Immune Status: Weakened immunity (e.g., from HIV/AIDS or immunosuppressive therapy) increases risk.
• Epstein-Barr Virus: Prior infection is strongly associated with this subtype.

Symptoms

• Painless swelling of lymph nodes in the head, face, or neck.
• Persistent fatigue or weakness.
• Unexplained fever or night sweats.
• Unintended weight loss.
• Itchy skin (pruritus).
• Cough or difficulty breathing if lymph nodes press on airways.

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging studies (e.g., CT or PET scans), and biopsy of affected lymph nodes. Pathological examination confirms the presence of Reed-Sternberg cells and the lymphocyte-depleted pattern. Staging determines the extent of disease, which guides treatment planning.

Treatment Options

Treatment typically includes chemotherapy, often combined with radiation therapy for localized disease. Stem cell transplantation may be considered for advanced or refractory cases. Targeted therapies and immunotherapies are under investigation for improving outcomes.

Prognosis and Follow-Up

Prognosis is generally poorer than other Hodgkin lymphoma subtypes due to its aggressive nature, but treatment advances have improved survival rates. Regular follow-up with imaging and clinical assessments is essential to monitor for recurrence or complications.

Complications

• Disease progression or recurrence.
• Infection due to weakened immune system.
• Long-term effects of chemotherapy or radiation (e.g., secondary cancers).
• Lymphedema or nerve damage from lymph node involvement.

Lifestyle & Prevention

• Maintain a healthy immune system through balanced nutrition and regular exercise.
• Avoid known risk factors, such as smoking or excessive alcohol use.
• Stay up-to-date with vaccinations, especially if immunocompromised.
• Seek prompt medical attention for persistent lymph node swelling or other symptoms.

When to Seek Professional Help

Consult a healthcare provider if you experience persistent, painless lymph node swelling in the head, face, or neck, or unexplained symptoms like fever, night sweats, or weight loss. Early evaluation is critical for timely diagnosis and treatment.

Tips for Medical Coders

When coding for C81.31, ensure the documentation specifies involvement of lymph nodes in the head, face, or neck. Verify that the diagnosis aligns with the lymphocyte-depleted subtype of Hodgkin lymphoma. Confirm no conflicting documentation (e.g., extranodal involvement) that would require a different code. Use this code only when the site is explicitly documented as head, face, or neck lymph nodes.